AMEX: MTNB       Matinas Biopharma Hl
Last Price Today's Change   Day's Range   Trading Volume
1.49   +0.02 (1.36%)  1.45 - 1.58  5,808,600


Avg Volume (4 weeks):4,292,433
4 Weeks Range:1.26 - 2.49
4 Weeks Price Volatility (%):
52 Weeks Range:0.582 - 2.49
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Matinas BioPharma Holdings Inc is a US-based clinical-stage biopharmaceutical company which focuses on developing anti-infectives for orphan indications. The company's lead product candidate MAT2203 is an orally-administered cochleate formulation of a broad spectrum anti-fungal drug called amphotericin B and other clinical stage product candidate is MAT2501 which is a an orally administered, encochleated formulation of the broad spectrum aminoglycoside antibiotic amikacin which treats different types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections as well as various multidrug-resistant gram negative and intracellular bacterial infections.

  Be the first to like this.


3414  4674  636  186 

Top 10 Active Counters
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers